Clinical Trials for Erythema

Clinical trials are research studies conducted in an effort to improve overall patient health and care. Each trial involves running supervised tests to determine the effectiveness and safety of new drugs, procedures and/or devices with the aim of answering scientific questions about a disease or condition. Risks and side-effects are also evaluated during these trials with results ranging from being unpleasant, with side effects such as headaches, to more serious or even life-threatening risks. A clinical trial may be separated into phases, or steps, with each step designed to answer a separate research question. This maybe reflected in the trial name.

A brief description of each phase:

• Phase I: Usually designed to evaluate safety, determine a safe dosage range, and identify side effects on a small group of patients.
• Phase II: If Phase I is successful, the trial is then repeated with a larger group to further evaluate its effect and safety.
• Phase III: Trials are conducted on an ever larger group and are compared with the best current treatment while gathering more information on effect and safety.
• Phase IV: These studies monitor long-term side effects after the treatment has been marketed.

Clinical Trials data for Erythema is grouped into the following categories:-

• View by trial name
• View by drugs used in Erythema clinical trials

Clinical Trials by trial name

The format for each of the following is:

• The name of the trial,
• followed by whether the trial is recruiting patients,
  - The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
  - Note**: Please follow the link to determine the current trial status.
• followed by a list of drug/s, if any, used in the trial

ClinicalTrials.gov has listed the following trials for Erythema:

• Analysis of Lyme Disease Lesions - This study is currently recruiting patients (Current: 23 Nov 2006)
• STEPP: A Phase 2, Open-Label, Randomized Clinical Trial of Skin Toxicity Treatment of Subjects Receiving Second-Line FOLFIRI or Irinotecan Only Chemotherapy Concomitantly With Panitumumab - This study is currently recruiting patients (Current: 23 Nov 2006) - Panitumumab
• Autologous Ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface Transplantation - This study is currently recruiting patients (Current: 23 Nov 2006)
• B-19 Parvovirus Vaccine Study - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• Erythema Toxicum Neonatorum in Newborns and the Development of Asthma - This study is currently recruiting patients (Current: 23 Nov 2006)
• Positron Emission Tomography (PET) to Locate Areas of White Blood Cell Activity - This study has been completed (Current: 23 Nov 2006) - 2-deoxy-2 [F-18] fluoro-2-d-glucose
• Topical Agent for Treatment of Red Skin - This study is currently recruiting patients (Current: 23 Nov 2006) - Investigational Topical Agent
• Investigation of Southern Tick-Associated Rash Illness (STARI) - This study is currently recruiting patients (Current: 23 Nov 2006)
• Minimal Erythema Dose of UV-B in Normal Population of Taiwan - This study has been completed (Current: 23 Nov 2006)
• A Phase II, Randomized Study of ACZONE (Dapsone) Gel, 5% for Papulopustular Rosacea. - This study has been completed (Current: 23 Nov 2006) - Vehicle control, 2x/day,ACZONE (dapsone) Gel, 5%, 2x/day,ACZONE (dapsone) Gel, 5%, 1x/day,MetroGel® (metronidazole gel), 1.0% 1x/day,ACZONE (dapsone) Gel, 5%, 1x/day (AM) + MetroGel (metronidazole gel), 1.0%, 1x/day (PM)
• Antibiotic Efficacy in Third Molar Surgery - This study is currently recruiting patients (Current: 23 Nov 2006) - IV Preoperative antibiotic or placebo
• Determining the Photoadaptation (Tolerance) of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo - This study is currently recruiting patients (Current: 23 Nov 2006)

Drugs used in Clinical Trials for Erythema

The format for each of the following is:

• The drug,
• followed by the name of the trial,
• followed by whether the trial is recruiting patients,
  - The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
  - Note**: Please follow the link to determine the current trial status.

ClinicalTrials.gov has listed the following drugs in trials for Erythema:

• 2-deoxy-2 [F-18] fluoro-2-d-glucose - Positron Emission Tomography (PET) to Locate Areas of White Blood Cell Activity - This study has been completed (Current: 23 Nov 2006)
• ACZONE (dapsone) Gel, 5%, 1x/day (AM) + MetroGel (metronidazole gel), 1.0%, 1x/day (PM) - A Phase II, Randomized Study of ACZONE (Dapsone) Gel, 5% for Papulopustular Rosacea. - This study has been completed (Current: 23 Nov 2006)
• ACZONE (dapsone) Gel, 5%, 1x/day - A Phase II, Randomized Study of ACZONE (Dapsone) Gel, 5% for Papulopustular Rosacea. - This study has been completed (Current: 23 Nov 2006)
• ACZONE (dapsone) Gel, 5%, 2x/day - A Phase II, Randomized Study of ACZONE (Dapsone) Gel, 5% for Papulopustular Rosacea. - This study has been completed (Current: 23 Nov 2006)
• IV Preoperative antibiotic or placebo - Antibiotic Efficacy in Third Molar Surgery - This study is currently recruiting patients (Current: 23 Nov 2006)
• Investigational Topical Agent - Topical Agent for Treatment of Red Skin - This study is currently recruiting patients (Current: 23 Nov 2006)
• MetroGel® (metronidazole gel), 1.0% 1x/day - A Phase II, Randomized Study of ACZONE (Dapsone) Gel, 5% for Papulopustular Rosacea. - This study has been completed (Current: 23 Nov 2006)
• Panitumumab - STEPP: A Phase 2, Open-Label, Randomized Clinical Trial of Skin Toxicity Treatment of Subjects Receiving Second-Line FOLFIRI or Irinotecan Only Chemotherapy Concomitantly With Panitumumab - This study is currently recruiting patients (Current: 23 Nov 2006)
• Vehicle control, 2x/day - A Phase II, Randomized Study of ACZONE (Dapsone) Gel, 5% for Papulopustular Rosacea. - This study has been completed (Current: 23 Nov 2006)

The trial data on this page has been sourced from

• The U.S. National Library of Medicine (NLM) together with ClinicalTrials.gov

 » Next page: Images relating to Erythema

Rate This Website

What do you think about the features of this website? Take our user survey and have your say:

Website User Survey

Medical Tools & Articles:

Next articles:

• Images relating to Erythema
• Erythema (Handbook of Signs & Symptoms (Third Edition))
• Erythema Multiforme (A Pocket Manual of Differential Diagnosis)
• Erythema Nodosum (A Pocket Manual of Differential Diagnosis)
• Erythema [Erythroderma] (Professional Guide to Signs & Symptoms (Fifth Edition))

Tools & Services:

• Bookmark this page
• Take a survey relating to Erythema
• Symptom Search
• Symptom Checker
• Medical Dictionary
• Give your feedback

Medical Articles:

• Disease & Treatments Search
• Misdiagnosis Center
• Full list of interesting articles

Forums & Message Boards

• Ask or answer a question at the Boards:
• I cannot get a diagnosis. Please help.
• Tell us your medical story.
• Share your misdiagnosis story.
• What is the best treatment for my condition?
• See all the Boards.

Enter your search terms Submit search form
Search The Web Search wrongdiagnosis.com

Common Health Mistakes

Symptom
Checker

Search Specialists by State and City